Evidence map›Paper›PMID 28536290›Full record

ArticlemBio2017

Peptidoglycan Association of Murein Lipoprotein Is Required for KpsD-Dependent Group 2 Capsular Polysaccharide Expression and Serum Resistance in a Uropathogenic

Jingyu Diao, Catrien Bouwman, Donghong Yan, Jing Kang, Anand K Katakam, Peter Liu, Homer Pantua, Alexander R Abbas, Nicholas N Nickerson, Cary Austin and 5 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Peptidoglycan LD-Transpeptidases.Antibiotics (Basel, Switzerland) · 2025
    Review
  3. Cell surface (Amsterdam, Netherlands) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Tol-Pal system of Acinetobacter baumannii is important for cell morphology, antibiotic resistance and virulence.International microbiology : the official journal of the Spanish Society for Microbiology · 2023
    Article
  10. Article
  11. Deletion of a previously uncharacterized lipoprotein lirL confers resistance to an inhibitor of type II signal peptidase inProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  12. Article
  13. "Omics" Technologies - What Have They Told Us About UropathogenicFrontiers in cellular and infection microbiology · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Jingyu DiaoDepartment of Infectious Diseases, Genentech, South San Francisco, California, USA.
Catrien BouwmanDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, ON, Canada.
Donghong YanDepartment of Translational Immunology, Genentech, South San Francisco, California, USA.
Jing KangDepartment of Translational Immunology, Genentech, South San Francisco, California, USA.
Anand K KatakamDepartment of Pathology, Genentech, South San Francisco, California, USA.
Peter LiuDepartment of Protein Chemistry, Genentech, South San Francisco, California, USA.
Homer PantuaDepartment of Infectious Diseases, Genentech, South San Francisco, California, USA.
Alexander R AbbasDepartment and Bioinformatics, Genentech, South San Francisco, California, USA.
Nicholas N NickersonDepartment of Infectious Diseases, Genentech, South San Francisco, California, USA.
Cary AustinDepartment of Pathology, Genentech, South San Francisco, California, USA.
Mike ReicheltDepartment of Pathology, Genentech, South San Francisco, California, USA.
Wendy SandovalDepartment of Protein Chemistry, Genentech, South San Francisco, California, USA.
Min XuDepartment of Translational Immunology, Genentech, South San Francisco, California, USA.
Chris WhitfieldDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, ON, Canada cwhitfie@uoguelph.ca kapadia.sharookh@gene.com.ORCID 0000-0002-5267-7027
Sharookh B KapadiaDepartment of Infectious Diseases, Genentech, South San Francisco, California, USA cwhitfie@uoguelph.ca kapadia.sharookh@gene.com.
University of Guelph · CA

Funding

CIHR FDN-148364
6 · The paper itself

Abstract

Murein lipoprotein (Lpp) and peptidoglycan-associated lipoprotein (Pal) are major outer membrane lipoproteins in

Indexed as

AnimalsBacteremiaBacterial CapsulesBacterial Outer Membrane ProteinsBlood Bactericidal ActivityDisease Models, AnimalEscherichia coli InfectionsEscherichia coli ProteinsLipoproteinsMiceMicrobial ViabilityMutationPeptidoglycanPeriplasmic ProteinsSerumUropathogenic Escherichia coliBacterial Outer Membrane ProteinsEscherichia coli ProteinsExcC protein, E coliKpsD protein, E coliLipoproteinsLpp protein, E coliPeptidoglycanPeriplasmic Proteinscapsular polysaccharidecell envelopecomplement resistanceEscherichia colimurein lipoproteinpolysaccharide export

Identifiers

PMID28536290
PMCPMC5442458
OpenAlexW2617468904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.